Loading news...
111 Capital purchased a new position in shares of CVS Health Corporation (NYSE: CVS) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 14,952 shares of the pharmacy operator's stock, valued at approximately $1,127,000. Other institutional investors and hedge funds have also recently added
Andra AP fonden bought a new position in shares of CVS Health Corporation (NYSE: CVS) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 370,800 shares of the pharmacy operator's stock, valued at approximately $27,955,000. Other hedge funds have also added to or reduced
CVS Health is making changes that could improve its business this year. Vertex Pharmaceuticals should see strong commercial and clinical progress in 2026.
Lansforsakringar Fondforvaltning AB publ grew its stake in CVS Health Corporation (NYSE: CVS) by 2.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 398,612 shares of the pharmacy operator's stock after acquiring an additional 8,992 shares during the quarter. Lansforsakringar Fondforvaltning
NewEdge Wealth LLC cut its holdings in CVS Health Corporation (NYSE: CVS) by 52.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,899 shares of the pharmacy operator's stock after selling 18,855 shares during the period. NewEdge Wealth LLC's holdings
Bleakley Financial Group LLC lifted its stake in CVS Health Corporation (NYSE: CVS) by 140.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 64,486 shares of the pharmacy operator's stock after acquiring an additional 37,721 shares during the quarter. Bleakley
China Universal Asset Management Co. Ltd. cut its holdings in shares of CVS Health Corporation (NYSE: CVS) by 22.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,300 shares of the pharmacy operator's stock after selling 6,700 shares during the quarter. China
Stock News Zuckerberg testifies in youth harm case: Meta Platforms (META) CEO Mark Zuckerberg defended Instagram's design and policies in a Los Angeles trial ov
The Vanguard Short Term Corporate Bond ETF and the Vanguard Short Term Bond ETF are both designed for conservative investors. One focuses more on corporate bonds to offer higher income, while the other targets U.S. Treasuries for stability. This comparison explains how each option can affect your returns, helping you choose the one that best fits your goals.
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Investment aims to strengthen the pharmacy workforce and expand access to care across the state BATON ROUGE, La., Feb. 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced the launch of a new $5 million scholarship program designed to support aspiring pharmacists in the state of Louisiana.
Insights into Glenview Capital Management's Fourth Quarter 2025 Moves Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the fourth quarte
Insight into Mark Hillman (Trades, Portfolio)'s Fourth Quarter 2025 Investment Moves Mark Hillman (Trades, Portfolio) recently submitted the 13F filing for the
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Exploring the Latest 13F Filing and Investment Adjustments Introduction to Prem Watsa (Trades, Portfolio) Prem Watsa (Trades, Portfolio), a prominent figure in
Colrain Capital LLC raised its position in shares of CVS Health Corporation (NYSE: CVS) by 27.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 131,205 shares of the pharmacy operator's stock after purchasing an additional 27,863 shares during
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Senator John Boozman (R-Arkansas) recently sold shares of Union Pacific Corporation (NYSE: UNP). In a filing disclosed on February 15th, the Senator disclosed that they had sold between $1,001 and $15,000 in Union Pacific stock on January 29th. Senator John Boozman also recently made the following trade(s): Sold $1,001 - $15,000 in shares of Omnicom Group
Senator John Boozman (R-Arkansas) recently sold shares of Micron Technology, Inc. (NASDAQ: MU). In a filing disclosed on February 15th, the Senator disclosed that they had sold between $1,001 and $15,000 in Micron Technology stock on January 26th. Senator John Boozman also recently made the following trade(s): Sold $1,001 - $15,000 in shares of Omnicom Group
Senator John Boozman (R-Arkansas) recently sold shares of abrdn Physical Platinum Shares ETF (NYSEARCA:PPLT). In a filing disclosed on February 15th, the Senator disclosed that they had sold between $1,001 and $15,000 in abrdn Physical Platinum Shares ETF stock on January 23rd. Senator John Boozman also recently made the following trade(s): Sold $1,001 - $15,000